A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model  by Lopes, Luciana B. et al.
A novel cell permeant peptide inhibitor of
MAPKAP kinase II inhibits intimal hyperplasia in
a human saphenous vein organ culture model
Luciana B. Lopes, PhD,a,e Colleen M. Brophy, MD,a,b,c Charles R. Flynn, PhD,a,b Zhengping Yi, PhD,a
Benjamin P. Bowen, PhD,a Christopher Smoke, BS,a Brandon Seal, PhD,d Alyssa Panitch, PhD,d and
Padmini Komalavilas, PhDa,b,c Tempe, Ariz; Nashville, Tenn; Purdue, Ind; and Albany, NY
Objective: The present study was aimed at developing a new cell-permeant peptide inhibitor (MK2i) of the kinase that
phosphorylates and activates heat-shock protein (HSP)27 (MAPKAP kinase II), and evaluating the ability of this peptide
to inhibit HSP27 phosphorylation and intimal thickening.
Methods:The ability ofMK2i to reduceHSP27 phosphorylation and cell migration was evaluated in A7R5 cells stimulated
with arsenite or lysophosphatidic acid. Stable isotopic labeling using amino acids in cell culture, in combination with
liquid chromatography mass spectrometry, was used to characterize the effect of MK2i on global protein expression in
fibroblasts. The effect of MK2i on intimal thickening and connective tissue growth factor expression was evaluated in
human saphenous vein (HSV) rings maintained with 30% fetal bovine serum for 14 days by light microscopy and
immunoblotting.
Results: Pretreatment of cells with MK2i (10 M) prior to arsenite or lysophosphatidic acid stimulation decreased
phosphorylation of HSP27 (36% 9% and 33% 10%, respectively) compared with control (not pretreated) cells. MK2i
also inhibited A7R5 migration, and downregulated the transforming growth factor-induced expression of collagen and
fibronectin in keloid cells, two major matrix proteins involved in the development of intimal hyperplasia. Treatment of
HSV segments withMK2i enhanced relaxation, reducedHSP27 phosphorylation (40% 17%), connective tissue growth
factor expression (17%  5%), and intimal thickness (48.2%  10.5%) compared with untreated segments. On the other
hand, treatment with a recombinant fusion protein containing a cell-permeant peptide attached to the HSP27 sequence
increased intimal thickness of HSV segments by 48%  14%.
Conclusion:Our results suggest thatHSP27may play a role in the development of processes leading to intimal hyperplasia
in HSV, and reduction of HSP27 phosphorylation by MK2i may be a potential strategy to inhibit the development of
intimal hyperplasia in HSV to prevent the autologous vascular graft failure. ( J Vasc Surg 2010;52:1596-1607.)
Clinical Relevance: Intimal hyperplasia represents the leading cause of prosthetic and autologous vascular graft failure. In
spite of the many recent technological advances in vascular interventions, intimal hyperplasia remains an expensive,
morbid, and unsolved problem, and this study presents a new strategy in the battle against such a disorder. Cell-permeant
peptide-based therapeutics was able to target MAPKAP kinase II and reduce HSP27 phosphorylation, and as a result,
prevent the development of intimal hyperplasia. This peptide acts downstream in the signaling cascade compared with
other compounds, and therefore may generate less adverse effects. Vein grafts represent an ideal target for cell-permeant
peptide therapeutics in that the grafts can be treated ex vivo at the time of surgery. Recent data suggest that the peptides
are present intracellularly for up to 7 days in cultured fibroblasts.Intimal hyperplasia represents the leading cause of
prosthetic and autologous vascular graft failure.1 Despite
the many recent technological advances in vascular inter-
From the Center for Metabolic Biology, Arizona State University,a the
School of Medicine, Vanderbilt University Medical Center,b the VA
Tennessee Valley Health Care System,c the Weldon School of Biomedical
Engineering, Purdue University,d and the Albany College of Pharmacy
and Health Sciences.e
Supported by National Institutes of Health Grant RO1HL70715 and a
Veterans Administration Merit Review (CMB).
Competition of interest: none.
Reprint requests: Colleen Brophy, MD, School of Medicine, Vanderbilt
University Medical Center, D-5237 MCN, 1161 21st Ave. South, Nash-
ville, TN 37232-2735(e-mail: colleen.brophy@vanderbilt.edu).
The editors and reviewers of this article have no relevant financial relationships to
disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a competition of interest.
0741-5214/$36.00
Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.
doi:10.1016/j.jvs.2010.06.168
1596ventions, intimal hyperplasia remains an expensive, morbid,
and unsolved problem.2 While incompletely understood,
intimal hyperplasia involves a response to injury and is
mediated by a sequence of events that include smooth
muscle cell proliferation, migration, phenotypic modula-
tion, and extracellular matrix deposition.3
Heat-shock protein (HSP)27 (also termed HSPB1,
HSP25) is a member of the family of small heat-shock
proteins. The expression and phosphorylation of HSP27
increase with stress. Increases in the phosphorylation of
HSP27 are associated with enhanced cell migration4,5 and
with abundant stress fiber formation,6,7 effects attributed
to HSP27 stabilization of the actin cytoskeleton. In addi-
tion to cell migration, stabilization of the cytoskeleton is
also associated with the expression of extracellular matrix
proteins,8-10 another key event related to intimal hyperpla-
sia. Therefore, because HSP27 expression and phosphory-
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events associated with intimal hyperplasia, modulation of
its phosphorylation may be a target to prevent intimal
hyperplasia.
The goal of the present study was to develop a cell-
permeant peptide inhibitor (named MK2i) of the kinase
that phosphorylates and activates HSP27 and to evaluate its
potential as a new strategy to prevent intimal hyperplasia.
HSP27 is phosphorylated by a kinase cascade that involves
p38 MAP kinase, which phosphorylates and activates
MAPKAP kinase II, which, in turn, phosphorylates
HSP27. To date, HSP27 is the only heat-shock protein
known to be phosphorylated by MAPKAP kinase II.11
While small molecule inhibitors of p38 MAP kinase have
been developed, toxicity has limited the clinical use of these
inhibitors.4 We developed MK2i using a protein transduc-
tion domain and a modification of a peptide designed by
Hayess and Benndorf that binds to and inhibits the catalytic
site of MAPKAP kinase II.12 Protein transduction domains
(PTDs) were used because of their ability to carry other
peptides, proteins, and even small particles across cell mem-
branes.13 In this study, we evaluated the effect of MK2i on
the phosphorylation of HSP27, cell migration, global protein
expression, and intimal thickening. Our results demonstrate
the potential of MK2i to prevent intimal hyperplasia.
MATERIAL AND METHODS
Materials. MK2i (WLRRIKAWLRRIKALNRQLGVAA)
was synthesized and purified using standard FMOC (9-
fluorenylmethyloxycarbonyl) chemistry and high-pressure
liquid chromatography. All chemicals were purchased from
Sigma Chemical Co (St Louis, MO) unless specified other-
wise.
Cell culture. A7R5 cells (embryonic rat aortic smooth
muscle cells) were purchased from ATCC (Manassas, Va)
and were grown at 37°C and 5% CO2 in Dulbecco’s
modification of Eagle’s medium (DMEM) containing 10%
fetal bovine serum, penicillin, and streptomycin (1%), in
60-mm2 dishes.When the cells reached 70% confluence, they
were growth-arrested by using a medium containing 1% bo-
vine serum albumin for 24 hours prior to each experiment.
A7R5 cells were chosen because this is a well-characterized
smooth muscle cell line, often used in cell migration assays,
and sensitive to transforming growth factor (TGF) and lyso-
phosphatidic acid (LPA) stimulations, mediators related to
the development of intimal hyperplasia.14
Cell treatment. On the day of each experiment, fresh
media (containing 1% bovine serum albumin) was added to
the dishes, and cells were either untreated (control) or
pre-treated with MK2i (5, 10, or 20 M) or with 20 M
SB203580 (SB, a p38 MAP kinase inhibitor; Cal Biochem,
San Diego, Calif) for 2 hours. For comparison, cells were
also treated with the commercial peptide inhibitor of
HSP27 phosphorylation that is not cell permeant (BN, 10
M).12 The cells were then stimulated with LPA (25 M)
for 1 hour or sodium arsenite (ARS; 500 M) for 0.5
hours as described earlier.18 Stimulation with LPA orARS has been demonstrated to increase the phosphory-
lation of HSP27.15,16 At the end of the experiments,
cells were rinsed with phosphate buffered saline (PBS),
quick-frozen, and protein-extracted using urea-DTT-
CHAPS buffer (8 M urea, 10 mM dithiothreitol
[DTT]4% 3-[(3-Cholamidopropyl)dimethylammonio]-
1-propanesulfonate [CHAPS]).
Cell migration. Migration was studied using a
scratch-wound motility assay. The scratch-wound assay has
been used for nearly half a century as an in vitro model of
wound healing and as a tool to discover factors important
for cell migration.17 For this assay, A7R5 cells were cul-
tured in a six-well dish and allowed to reach confluence; a
linear scratch (2 mm wide) was performed with a 10-L
pipette tip across the diameter of the well and rinsed with
PBS. Cells were kept in serum-free medium for 24 hours,
pretreated withMK2i at 10 M for 2 hours, and stimulated
with LPA, which stimulates migration of smooth muscle
cells.14 Pictures were taken on a Zeiss Axiovert 200 M
epifluorescence microscope (Carl Zeiss Inc, Thornwood,
NY), at a magnification of 20 and 40 X at 0 and 48 hours,
and the number of cells that invaded the scratch was
determined.
Stable isotopic labeling of cells in culture. To deter-
mine the effect of MK2i on global protein expression,
model system human dermal keloid fibroblasts were used.
The choice of keloid fibroblasts was based on the fact that
TGF- effects are better characterized in these cells com-
pared with endothelial or smooth muscle cells. Since
TGF- is an important mediator of intimal hyperplasia
(causing matrix production and deposition, smooth muscle
-actin expression and myofibroblast differentiation18), we
opted to use a cell model in which TGF- effects are well
described. Also, our earlier investigation had characterized
the effect of MK2i peptide on the TGF--induced phos-
phorylation of HSP27 and expression of connective tissue
growth factor and collagen I in keloid fibroblasts, a wound-
healing model.19 In addition, keloid fibroblasts express
robust stress fibers and -smooth muscle actin, character-
istics that confer some similarity to smooth muscle cells.
Fibroblasts were cultured in 60-mm dishes in the pres-
ence of one of the isotopic medias (with labeled aminoacid,
arginine, lysine, or cysteine) containing 10% dialyzed fetal
bovine serum (FBS). Cells cultured in these media for six
passages achieved a 98.9% incorporation of isotopic amino
acids (data not shown). The workflow of cell manipulation
is shown in Fig 1. Cells potentiated in 0.5% dialyzed FBS
for 48 hours prior to treatment were treated for 24 hours
with 1) a control – untreated; 2) TGF-1 (1.25 ng/mL) or
3) TGF-1 (1.25 ng/mL)  10 M MK2i. After treat-
ment, cells were washed in PBS then harvested by scraping
in urea/DTT/CHAPS buffer. Protein extracts from each
medium (25 g each) were combined 1:1:1 based on the
Coomassie Plus protein assay. The pooled protein extracts
were separated on 4% to 20% precast gradient sodium
dodecyl sulfate-polyacrylamide gels and visualized with
Coomassie blue. The resulting gel lane from each experiment
was cut into 20 slices of approximately equal size. High-
ted, a
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mass spectrometry was performed on a linear ion trap mass
spectrometer LTQ-Fourier Transform Ion Cyclotron Reso-
nancemass spectrometer (LTQFT; Thermo Fisher, San Jose,
Calif) fitted with a PicoView nanospray source (New Objec-
tive, Woburn, Mass) as described.20 The search parameters
used for both RAW and DAT file searches were: 0.5 Da mass
tolerance for precursor ionmasses and10ppm for product ion
masses; digestion with trypsin/p; a maximum of two missed
tryptic cleavages; variablemodifications of oxidation ofmethi-
onine and phosphorylation of serine, threonine, and tyrosine,
6 on lysine (13C6 label),6 on arginine (13C6 label),10
on arginine (U-13C6,U-15N4 label),17on lysine (U-2H9,
U-13C6, U-15N2), and 57 on cysteine (carbamidomethy-
lation). Probability assessment of peptide assignments and
protein identificationswithin “DAT”filesweremade through
use of Scaffold (version Scaffold-01_07_17; Proteome Soft-
ware Inc, Portland, Ore). Only peptides with95% probabil-
ity as considered by the ProteinProphet algorithm were in-
Fig 1. Schematic of workflow used for a three-way SIL
labeled with normal and stable isotope-substituted ar
populations distinguishable by mass. Each population
combined in equal amounts (25 g each), trypsin-digescluded in the final table. Criteria for protein identificationincluded detection of at least two unique identified peptides
and a probability score of 99%. Proteins were quantified
using the MSQuant Suite of software (http://msquant.
sourceforge.net/) as described.21
Construction of cell-permeant HSP27 fusion
protein. The cDNA encoding human HSP27 was poly-
merase chain reaction amplified from an I.M.A.G.E (Inte-
grated Analysis of Gene Expression). Clone (clone ID
6083486; Clontech, Palo Alto, Calif) using a for-
ward primer (5’-GATCGAGCTCATGACCGAGCGC-
CGCGTC-3’) and a reverse mutagenic primer (5’-gatcgg-
taccttacttggcggcagtctcatcgg-3’) then cloned into pCDNA3.1
(Invitrogen, Carlsbad, Calif), yielding pCDNA3.1-HSP27.
Complementary oligonucleotides (5’-TATGGGTG-
GTTATGCTAGAGCTGCTGCTAGACAAGCTA-
GAGCTGGTACCGAGCTCCTCGAGG-3’ and
5’-GATCCCTCGAGGAGCTCGGTACCAGCTCTA-
GCTTGTCTAGCAGCAGCTCTAGCATAACC-
ACCCA-3’) encoding a PTD were annealed, phosphory-
MS experiment. Three cell populations are isotopically
e (R) and lysine (K) amino acids, creating three cell
imulated as indicated yielding three samples that are
nd analyzed using mass spectrometry.AC-
ginin
is stlated, and ligated into NdeI-BamHI-digested pET14b
or the
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cDNA encoding HSP27 was liberated from pCDNA3.1-
HSP27 with SacI-XhoI digestion and ligated into SacI/
XhoI-digested pET14b-PTD yielding pET14b-PTD-
HSP27. Base sequences for all DNAs were confirmed by
nucleotide sequence analysis, and protein was expressed in
Escherichia coli. Briefly, single colonies of BL21 (DE3;
Novagen) containing recombinant pET14b-PTD-HSP27
were used to inoculate 3 liters of Luria Broth (LB) contain-
ing 50 mg/L of ampicillin. Cultures were induced with 2
mM isopropyl-1-thio--D-galactopyranoside when the op-
Fig 2. Effect of MK2i on the phosphorylation of HSP27
treated with arsenite (ARS, 500M) or lysophosphatidic
untreated or pretreated with MK2i (1, 5, or 10 M), SB
of MK2i (BN10 M) for 2 hours prior stimulation with A
by sodium dodecyl sulfate polyacrylamide gel electropho
quantified by densitometry. Phosphorylated HSP27 o
relative to actin expression. The ratio of phosphorylatedH
cells was set to one for comparison of different blots. Dat
separate experiments. *, P .05 compared with the untr
MK2i or SB; B: cells stimulated with LPA and treated w
and treated with BN; D and E: ratios of relative phosp
expression. The level of PKGwas monitored as a marker ftical density at 600-nm wavelength reached 0.6-1. After 5hours, cells were harvested by centrifugation (6,000 g, 10
minutes), resuspended in 1 TNE buffer (50 mMNaCl, 1
mM ethylenediaminetetraacetic acid [EDTA], and 500
mM Tris, pH 8.0), and sonicated on ice. After sonication,
the inclusion bodies were harvested by centrifugation
(19,000 g, 10 minutes) and resuspended in binding buffer
(20 mM Na2HPO4, 0.5 M NaCl, 50 mM imidazole, pH
7.4, and 8 M urea). The sample was then added to Ni2-
charged Chelating Sepharose Fast Flow (Pharmacia Bio-
tech, Peapack, NJ) and incubated overnight at 4°C. The
resin was then loaded into a Poly-Prep column (Bio-Rad,
7R5 cells. The cells were serum-starved for 24 hours and
(LPA, 25 M) for 0.5 hour or 1 hour. Cells were either
80 (20 M) or the non-cell-permeant peptide inhibitor
r LPA. The cells were homogenized, proteins separated
transferred to Immobilon membranes, and bands were
n-phosphorylated HSP27 expressions were quantified
/total HSP27 (relative p-HSP27/HSP27) in untreated
expressed as mean standard deviation for a set of four
rings (C). A: cells stimulated with ARS and treated with
K2i or SB; C: Cells stimulated with either ARS or LPA
lated/non-phosphorylated HSP27 normalized to actin
contractile phenotype of rat aortic smooth muscle cells.in A
acid
2025
RS o
resis,
r no
SP27
a are
eated
ith M
horyRichmond, Calif), and protein was eluted with 2mL of 500
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Na2HPO4, 0.5 M NaCl).
Muscle physiology. De-identified discarded seg-
ments of human saphenous vein (HSV) were collected after
the approval of the Institutional Review Board of the
Arizona Heart Institute (Phoenix, Ariz) from consented
patients undergoing coronary artery bypass or peripheral
vascular bypass surgery. To test the viability, rings (1.0 mm
in width) were cut from segments of saphenous vein,
dissected free of fat and connective tissue, stripped of the
endothelium (to focus on smooth muscle responses), and
contracted as described earlier.32 To test the effect of MK2i
on the relaxation of HSV, rings were washed in bicarbonate
buffer and incubated with either buffer (control), 25 M
SB, or 30 M MK2i for 2 hours. Rings were contracted
with norepinephrine (0.5 M) and relaxed with cumulative
log doses of sodium nitroprusside (0.01-1 M), a nitric
oxide donor.
Organ culture. After viability was determined in the
muscle bath, additional rings (3 mm in length) were cut,
placed in eight-well chamber slides, and maintained in
RPMI 1640 medium with 30% FBS, 1% L-glutamine, and
1% penicillin/streptomycin for 14 days at 37°C/5%CO2 as
described.32 The rings were either untreated, or treated
with MK2i (5 or 10 M), SB (25 M), or recombinant
HSP27 protein attached to a protein transduction domain
Fig 3. Effect of MK2i treatment on A7R5 cell migration induced
by lysophosphatidic acid (LPA). Migration assays were performed
by scratch wound motility assay. Cells were kept in serum-free
medium for 24 hours, pretreated withMK2i at 10 M for 2 hours,
and stimulated with LPA. For each well, pictures were taken on a
microscope at a magnification of 20 and 40 X at 0 and 48 hours,
and the number of cells that invaded the scratch was determined.
U, Untreated cells.for cell penetration (19 M). The experiments were con-ducted in duplicate for every vein segment: one set of rings
was used for histological evaluation, while the other set was
used for evaluation ofHSP27 phosphorylation and connec-
tive tissue growth factor (CTGF) expression by Western
blot. To study the effect ofMK2i on collagen accumulation
in cultured vein rings, control rings and those treated with
MK2i at 10 M were also stained for collagen using the
Masson’s trichrome stain.
The second set of rings was snap-frozen with liquid nitro-
gen, pulverized, and homogenized usingUrea-DTT-CHAPS
buffer. Lysates were centrifuged (6000 g, 20 minutes), and
the supernatant was collected for subsequent evaluation of
HSP27 phosphorylation and CTGF expression.
Immunoblot analysis. Protein from cells or HSV ring
lysates were electrophoretically separated, transferred to
Immobilon membranes, and analyzed by Western blotting
as described earlier10 with the following primary antibod-
ies: rabbit anti-CTGF (Torrey Pines Biolabs, Houston,
Tex), mouse anti-HSP27 (gift from Dr Michael Welsh,
University of Michigan), rabbit anti-phosphorylated
HSP27,22 and rabbit anti--actin (Sigma, St. Louis, Mo).
Statistical analysis. All protein expression data are
presented as means standard deviation. TheWestern blot
bands were quantified by densitometry, and proteins ex-
pression normalized from the amount of the loading con-
trol (-actin) expression. One-way analysis of variance fol-
lowed by Tukey test was used to compare experimental
groups, with a significance level of P  .05.
RESULTS
The effect of MK2i on HSP27 phosphorylation in
A7R5 cells. Treatment with ARS (0.5 mM) or LPA (25
M) increased the phosphorylation of HSP27 in A7R5
cells (Fig 2). Pretreatment with 10 M MK2i decreased
ARS and LPA-induced HSP27 phosphorylation by 36% 
9% and 33% 10%, respectively (P .05; Fig 2). Since rat
aortic smoothmuscle cells undergo changes in culture from
the contractile to a synthetic phenotype, the level of PKG
(cGMP-dependent protein kinase, a phenotypic marker of
smoothmuscle cells) was monitored, and experiments were
conducted only in cells expressing PKG (data not shown).
Several investigations have demonstrated that expression of
cyclic GMP-dependent protein kinase results in the expres-
sion of smooth muscle specific myosin heavy chains, calpo-
nin, and -smooth muscle actin, all markers considered to
be associated with the contractile phenotype.23,24
As a control, cells were also treated with the p38 MAP
kinase inhibitor SB. P38 MAP kinase acts upstream to
MAPKAP kinase II, phosphorylating and activating it. SB
pretreatment led to decreases in the phosphorylation of
HSP27 after stimulation with either ARS or LPA (71% 
7% or 52% 23%, respectively, compared with no SB, P
.05). Additionally, treatment with the peptide inhibitor of
MAPKAP kinase II that does not contain a protein trans-
duction domain (BN) did not lead to decreases in LPA- or
ARS-induced increases in the phosphorylation of HSP27
(Fig 2, C). This is likely due to the inability of this peptide
to penetrate into cells.
ptide
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was performed to determine the effect of MK2i on smooth
muscle cell migration stimulated by LPA.14MK2i (10 M)
pretreatment decreased LPA-induced migration by 52% 
16% (P  .05) compared with cells stimulated with LPA
but not pretreated with MK2i (Fig 3).
Proteomic profiling of MK2i-mediated protein
change. Stable isotopic labeling using amino acids in cell
culture (SILAC) in combination with liquid chromatogra-
phy (LC) mass spectrometryn (MS/MS) was used to char-
acterize cellular responses in human dermal keloid fibro-
blasts upon stimulation with TGF- that has demonstrated
to induce HSP27 phosphorylation.10 Fig 4 shows a typical
MS/MS mass spectra of an arginine-containing peptide
triplet (that is the same peptide derived from each of the
three different media/treatments) and that of a lysine-
containing peptide triplet. The isotopic envelope of a 2
charged peptide SLQEEHVAVAQLR, derived from the
protein histone H2 in Media 1, has a monoisotopic pro-
tonated mass of 1485.81 (yellow dot), a 6R amino acid
Fig 4. Mass spectra of eluting SILAC peptide triplets (th
accurate mass determination. The masses of the singly pro
above each spectra. Brackets above each peptide isotope
peptide. (A) Mass spectra of an arginine-containing tryp
derived from the protein histone H2 (H2A1). Red arr
masses from each peptide of the triplet. For example, the
derived from media one (740.40 Da) and media 2 (743.4
each species of a peptide isotopic envelope as a consequ
oxygen. In this example, the distribution of each peptide
of a lysine-containing tryptic peptide (VTIAQGGVLPNI
1 (PLEC1). In this example, the distribution of each pefrom Media 2 (1479.79, red dot), and the 10R labeledpeptide from Media 3 (1489.80, blue dot). The envelope
of each peptide reflects a typical distribution and is a con-
sequence of naturally-abundant carbon, nitrogen, oxygen,
and hydrogen atoms. The spacing of the monoisotopic
mass peaks from each 2 charged peptide envelope is
indicated by the red arrows. The relative intensities of each
monoisotopic mass peak are proportional to the abundance
of that peptide in the media. Fig 4B shows a similar mass
spectra for a lysine-containing 3-charged peptide triplet
derived from the protein plectin 1. The Table lists those
proteins most upregulated upon TGF- stimulation and
those most downregulated upon TGF-  MK2i treat-
ment. Of note, two extracellular matrix proteins implicated
in hyperplastic lesions, fibronectin and collagen, were
downregulated after MK2i treatment. MK2i not only de-
creased the phosphorylation of HSP27 but also decreased
its expression.
Effect of MK2i on the phosphorylation of HSP27
and expression of CTGF in cultured HSV rings. We
evaluated the effect of MK2i on the expression/phosphor-
e peptide from the three cell populations) measured for
ted peptide sequences derived from each media are listed
ter denote the isotopic amino acid incorporated in that
eptide (SLQEEHVAVAQLR) triplet (2 charge state)
ndicate the mass difference between the monoisotopic
difference between the doubly-charged (z 	 2) peptide
)	 3. Blue arrows delineate them/z difference between
of naturally occurring isotopes of carbon, nitrogen, and
rs at a 1:0.5:0.5m/z ratio (0:6:10). (B) Mass spectra
LLPK) triplet (3 charge state) derived from the plectin
occurs at a 1:0.6:1 m/z ratio (0:6:17).e sam
tona
clus
tic p
ows i
m/z
1 Da
ence
occu
QAVylation of HSP27 and CTGF in cultured HSV rings used as
GF-
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decreased the phosphorylation of HSP27 by 40%  17%
(P  .05; Fig 5, A and B) while SB decreased the phos-
phorylation of HSP27 by 58%  22% (P  .05) compared
with untreated controls.
CTGF has been proposed to mediate some of the
pro-fibrotic effects of TGF- (and other pro-fibrotic medi-
ators) including production of extracellular matrix pro-
teins. An intact cytoskeleton is required for CTGF expres-
sion.8 Since HSP27 phosphorylation is associated with
actin cytoskeleton stabilization, we hypothesized that re-
duction of HSP27 phosphorylation would reduce CTGF
expression. The expression of CTGF was decreased by
Table. Protein expression results identified through SILA
Gene name Protein name
Proteins most upregulated with TGF-
CO1A1_HUMAN Collagen alpha-1(I) chain precursor
BLVRB_HUMAN Biliverdin reductase B
MYO1C_HUMAN Myosin-Ic
CKAP4_HUMAN Cytoskeleton-associated protein 4
SPTA2_HUMAN Spectrin alpha chain, brain
HSP71_HUMAN Heat shock 70 kDa protein 1
ANXA2_HUMAN Annexin A2 (lipocortin II)
FINC_HUMAN Fibronectin precursor
LIMA1_HUMAN LIM domain and actin-binding prote
ARP2_HUMAN Actin-like protein 2
CH60_HUMAN 60-kDa heat shock protein, mitochond
LDHA_HUMAN L-lactate dehydrogenase A chain
PEA15_HUMAN Astrocytic phosphoprotein PEA-15
EZRI_HUMAN Ezrin
TPM4_HUMAN Tropomyosin alpha-4 chain
MOES_HUMAN Moesin
DUS3_HUMAN Dual-specificity protein phosphatase 3
CO6A1_HUMAN Collagen alpha-1(VI) chain precursor
ANXA4_HUMAN Annexin A4 (Lipocortin IV)
RS2_HUMAN 40S ribosomal protein S2 (S4)
Proteins most downregulated with TGF-  inhibitor
RL23_HUMAN 60S ribosomal protein L23
VDAC1_HUMAN Voltage-dependent anion-selective cha
NDKA_HUMAN Nucleoside diphosphate kinase A
CO1A1_HUMAN Collagen alpha-1(I) chain precursor
RL27_HUMAN 60S ribosomal protein L27
CALR_HUMAN Calreticulin precursor
GSTO1_HUMAN Glutathione transferase omega-1
H4_HUMAN Histone H4
GLRX1_HUMAN Glutaredoxin-1
HSPB1_HUMAN Heat shock 27-kDa protein
CALD1_HUMAN Caldesmon
FKB1A_HUMAN FK506-binding protein 1A
ROA2_HUMAN Heterogeneous nuclear ribonucleoprot
TPM4_HUMAN Tropomyosin alpha-4 chain
HNRPD_HUMAN Heterogeneous nuclear ribonucleoprot
GSTM3_HUMAN Glutathione S-transferase Mu 3
ATP5L_HUMAN ATP synthase subunit g, mitochondria
CRYAB_HUMAN Alpha crystallin B chain (Heat-shock
BASP_HUMAN Brain acid soluble protein 1
ZYX_HUMAN Zyxin
Human dermal keloid fibroblasts treated with TGF- (1.25 ng/mL) and T
MSQuant-mediated protein quantification.17% 5% with MK2i (10 M), and by 28% 7% with SB,compared with untreated controls (P  .05; Fig 5, A and
C).MK2i also decreased TGF--inducedCTGF expression
in A7R5 cells (29%  11%; data not shown).
Effect of MK2i on the development of intimal
hyperplasia. Finally, we determined the effect of MK2i on
intimal thickening inHSV. The average intimal thickness of
the pre-cultured HSV was 15.8 3.4 m. After 14 days in
culture, the average intimal thickness of the untreated
(control) rings was 44.3  9.4 m, an increase of over
100% in the thickness of the intimal layer (Fig 6, A).
Treatment with MK2i (10 M) and SB significantly
reduced the intimal thickness by 48.2%  10.5% and
61.9%  5.4%, respectively, compared with untreated
sed proteomic profiling
Log2
TGF-:control ratio
Log2
TGF-MK2i:
control ratio
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hyperplasia, we generated a fusion protein containing recom-
binant HSP27 attached to a protein transduction domain to
allow cell penetration of the protein (r-HSP27). The rings
treated with r-HSP27 (19 M) developed an increase of
48% 14% (P .05) in intimal thickening compared with
control rings.
The ratio intimal/media layer for each treatment is
shown in Fig 6G. Again, a significant (P .05) decrease in
this ratio was observed when the rings were treated with
MK2i (at 10M) or SB compared with the untreated rings,
whereas r-HSP27 increased this ratio.
Since deposition of extracellular matrix proteins is a key
feature of intimal hyperplasia, we evaluated how MK2i
treatment affected collagen deposition in the vein rings.
Control rings and those treated with MK2i at 10 Mwere
stained for collagen using the Masson’s trichrome stain. As
can be seen in Fig 7, deposition of collagen was observed in
the neointima of untreated rings cultured for 14 days (Fig
7, A). Treatment with MK2i reduced collagen accumula-
tion (Fig 7, B).
MK2i enhances relaxation of HSV. We examined
Fig 5. Effect of MK2i or SB treatment on connective tis
heat-shock protein (HSP)27 in HSV rings. The vein
L-glutamine (1%), penicillin/streptomycin (1%), and FBS
untreated (C) or treated with MK2i (5 or 10 M) or
densitometry (panel A), and expression of phosphorylat
(panel C) were related to actin to correct for loading d
HSP27 in untreated rings was set to one for compariso
deviation of 6 experiments. *, P  .05 compared with ththe effect of inhibiting the phosphorylation of HSP27 onnitric oxide-induced relaxation of saphenous vein. HSV
rings were contracted with norepinephrine (0.5 M) and
relaxed with sodium nitroprusside (a nitric oxide donor
0.01-1 M), with or without preincubation with MK2i or
SB and the force generated was recorded. Preincubation of
HSV with 30 M MK2i increased sodium nitroprusside
(0.1 M)-induced relaxation from 18.47% 8% to 64.93%
 6.52% (Fig 8), while SB (25 M) increased relaxation
from 18.47%  8% to 50.5%  6.2%. MK2i did not affect
the contraction of HSV significantly at the concentration
used (data not shown).
DISCUSSION
The role of HSP27 in stabilizing the actin cytoskeleton
(which leads to several key events associated with intimal
hyperplasia) has been supported by several lines of evi-
dence. Transfection of cells with dominant active phos-
phorylatedmutants of HSP27 leads to abundant stress fiber
formation.6,7 The presence of central actin stress fibers in
cultured cells is associated with the “synthetic” or “myofi-
broblast” phenotype.25 HSP27 has also been shown to be
induced by stress, particularly in the vasculature.22,26 In-
rowth factor (CTGF) expression and phosphorylation of
were cultured in RPMI medium supplemented with
) at 5%CO2 and 37°C for 14 days. The rings were either
20 M). The Western blot bands were quantified by
SP27/non-phosphorylated HSP27 (panel B) or CTGF
nces. The expression of CTGF, HSP27, and phospho-
different blots. Data are expressed as mean  standard
treated rings (C).sue g
rings
(30%
SB (
ed H
iffere
n ofcreases in the phosphorylation of HSP27 are also associated
as the
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cle cells from the media to the hyperplastic lesion has been
implicated as one of the inciting events in intimal hyperpla-
sia.27 The expression and phosphorylation of HSP27 dou-
bles after exposure of human saphenous vein segments to
arterial flow ex vivo.28 Vein graft arterialization also leads to
activation of p38 MAPK.29 Hence, molecular strategies that
inhibit HSP27 phosphorylation would prevent smooth
muscle cell migration, phenotypic modulation to a myofibro-
blast, extracellular matrix production, and intimal hyperplasia.
In this study, we examined the effect of a cell-permeant
peptide inhibitor (MK2i) of the kinase that phosphory-
lates and activates HSP27, and evaluated its potential to
inhibit the phosphorylation of HSP27 and prevent inti-
mal hyperplasia. We used HSV cultured in the presence
Fig 6. Effect of MK2i, SB or r-heat-shock protein (HSP
show the intimal thickness. Vein rings (n 	 4-6 for each
L-glutamine (1%), penicillin/streptomycin (1%), and FBS
untreated (C) or treated with MK2i (5 or 10 M), SB (
fixed in formalin, sectioned at 10 m, and stained usingW
B: rings treated with MK2i at 5 M;C: rings treated with
treated with r-HSP27; F: intimal layer thickness, G: intim
in panels A-E indicate the internal elastic lamina, whereof high serum as an ex vivo model of intimal hyperplasia,which has been reported as a representative ex vivo
model of the changes following vein graft stenosis in
man30,31 and had been used previously in our laborato-
ry.32 Accordingly, marked similarities were previously
observed in the cellular and extracellular matrix compo-
sition in the intimal layer of the cultured vein and the
pathological lesion, with both showing abundance of
collagen and smooth muscle cells of secretory pheno-
type.33 Using bromodeoxyuridine as a proliferation
marker, it was observed that early cell proliferation in the
cultured vein intima gave rise to the neointima. Both
proliferation and neointimal thickness were maximal by
day 14 in culture, hence justifying the culture of rings for
14 days. Cell proliferation and increases in the cross-
sectional area of the medial layer have also been observed
reatment on the intimal layer thickening. The white bars
p) were cultured in RPMI medium supplemented with
) at 5%CO2 and 37°C for 14 days. The rings were either
), or r-HSP27 (19 M). After 14 days, the rings were
rt’s resorcin-fucsin.A: control rings cultured for 14 days;
2i at 10 M;D: rings treated with SB at 20 M; E: rings
edia layer ratio: Magnification: 40X. The white arrows
white bars indicate the thickness of the intimal layer.)27 t
grou
(30%
20 M
eige
MK
al/min this model.34
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LPA- and ARS-induced phosphorylation of HSP27 in a
smooth muscle cell line suggests the potential of this pep-
tide to penetrate into cells and target MAPKAP kinase II.
As expected, this effect was not observed when the peptide
inhibitor of MAPKAP kinase II was not attached to a
protein transduction domain (and therefore, not cell per-
meant), suggesting that the transduction domain is neces-
sary for adequate cell penetration of the peptide.
During the course of the intimal hyperplasia, the tissue
transitions from highly cellularized and proliferative to a
neointima dominated by matrix components, with fibrosis
becoming the prevailing event.35 Recent studies have im-
Fig 7. Accumulation of collagen in human saphenous vein
(HSV) rings. Rings were either untreated (A) or treated withMK2i
at 10 M (B) for 14 days. They were then stained for collagen
using Masson’s trichrome stain and observed under halogen light
(magnification 	 10).
Fig 8. The p38 MAP kinase inhibitor, SB 203580, and HSP27
kinase inhibitor, MK2i, enhances nitroprusside-induced relaxation
in saphenous vein. Saphenous veins were cut into rings, suspended
in a muscle bath, and equilibrated in Krebs Ringer bicarbonate
buffer for 2 hours. The rings were contracted with KCl (110 mM),
and force generated was measured to check for viability. The rings
were then pretreated with buffer (control), 25MSB203580 (SB),
or 30 MMK2i for 2 hours and then contracted with norepineph-
rine (NE, 0.5 M) and relaxed with increasing doses of sodium
nitroprusside (SNP, 0-1M). SB orMK2i treatment led to significant
increases in the relaxation of saphenous vein. *, P 	 .0335, #, P 	
.0108 at 0.1 M SNP compared with control, n	 3.plicated TGF-1 and CTGF as canonical mediators of bothphases of intimal hyperplasia since these growth factors are
involved in matrix production and deposition, smooth
muscle -actin expression, and myofibroblast differentia-
tion.18 While an increased expression of TGF-1 was ob-
served in hyperplastic tissue, TGF-1 antisense treatment
reduced intimal hyperplasia and stenosis in animal mod-
els.36 This and previous studies from our group demon-
strate that TGF-1 treatment increases phosphorylation of
HSP27 and production of connective tissue growth factor
(CTGF) and collagen (Table).19 Since several of the TGF-
and CTGF-mediated effects are dependent on MAPKAP
kinase II,37 MK2i has the potential to counteract such
effects.19 As demonstrated by SILAC method, a tool that
can determine the effect of agonists and drugs on global
protein expression,21 TGF-1 treatment increased the ex-
pression of two of the major extracellular matrix proteins
found in intimal hyperplastic lesions: collagen I and fi-
bronectin (Table). MK2i treatment decreased the expres-
sion of both proteins. Interestingly, HSP27 expression was
also regulated by MK2i. Recently, our group has evaluated
the effect of MK2i on TGF--induced phosphorylation of
HSP27 in keloid cells and demonstrated that, compared
with the TGF- stimulation, MK2i (10 M) significantly
diminishedHSP27 phosphorylation to levels similar to that
of the untreated control cells.19 Therefore, MK2i seems to
be involved in decreasing expression and phosphorylation
of HSP27. Upregulation of HSP27 in the smooth muscle
cells of saphenous vein was previously observed as a result of
vein exposure to simulated venous or arterial flow,28 fur-
ther supporting a role for HSP27 in tissue remodeling and
intimal hyperplasia.
Intimal injury is believed to be followed by release of
inflammatory mediators (such as growth factors and cyto-
kines) that induce phenotypic changes of vascular smooth
muscle cells from the quiescent “contractile” state to the
active “synthetic” state and their migration from the media
to the intimal layer. Once in the intima, these cells prolif-
erate (becoming the major cell type) and synthesize extra-
cellular matrix proteins, the predominant component of
intimal hyperplasia.35 Collagen is the most abundant ma-
trix protein, but hyaluronic acid and fibronectin are also
present.38 As can be seen in Fig 7, deposition of collagen
can be found in the neointima of rings cultured for 14 days
in high serum, whereas MK2i treatment prevented such
accumulation.
Treatment of the rings with MK2i significantly de-
creased the thickness of intimal layer compared with un-
treated HSV, while the opposite was observed for rings
treated with a recombinant fusion protein of HSP27
(r-HSP27). The reduction of intimal thickening was asso-
ciated with decreases in HSP27 phosphorylation, CTGF
expression, and collagen deposition. The fact that MK2i
decreased HSP27 expression in cells, phosphorylation, and
intimal thickening in cultured vein segments provides evi-
dences for the involvement of HSP27 in the actin cytoskel-
eton reorganization and development of intimal hyperpla-
sia. Because expression of CTGF is believed to depend on
an intact actin cytoskeleton, agents that compromise this
JOURNAL OF VASCULAR SURGERY
December 20101606 Lopes et alintegrity most likely have an effect in modulating CTGF
expression.9,10,39 CTGF has been implicated as an impor-
tant mediator of intimal hyperplasia due to its involvement
in collagen production, smooth muscle -actin expression,
and myofibroblast differentiation. Further investigation on
signaling cascades affected by MK2i and their link to
HSP27 phosphorylation and CTGF expression are still
necessary, but because increases in the phosphorylation of
HSP27 are associated with stabilization of the actin
cytoskeleton, it is reasonable to expect that by decreasing
HSP27 phosphorylation, MK2i affects CTGF expression
and, in turn, collagen deposition.
Taken together, these results demonstrate the potential
of using cell-permeant peptide-based therapeutics to target
MAPKAP kinase II and reduce HSP27 phosphorylation as
a strategy to inhibit the development of intimal hyperplasia
and enhance the patency of vein grafts.
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